Tulsa Cancer Institute is a clinical research site located in Tulsa, Oklahoma, United States 74146.
Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.
Tulsa Cancer Institute has participated in 35 clinical trials with 2 currently active.
Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, Celgene, Genentech, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oklahoma · View every site in Tulsa
Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tulsa Cancer Institute has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tulsa Cancer Institute has 35 clinical trials on record, with 2 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Epithelial Ovarian Cancer, Fallopian Tube Cancer.
Tulsa Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.